Therapeutics vs. Diagnostics and Breast Cancer Dominance: A Deep...

σε πρόσθεσε στο Wellness

2025-12-01 12:12:29 -

Therapeutics vs. Diagnostics and Breast Cancer Dominance: A Deep Dive into Precision Oncology Market Analysis

The Precision Oncology Market Analysis confirms that the market operates on two interconnected components: Therapeutics and Diagnostics. The Therapeutics segment consistently holds the largest revenue share (often exceeding 70% in 2024), driven by the high cost and value of targeted drugs, immunotherapies, and cell & gene therapies. However, the Diagnostics segment (e.g., NGS, liquid...

0 Σχόλια 0 Μοιράστηκε 256 Views 0 Προεπισκόπηση